Rituxan (rituximab) - Roche
Enspryng (satralizumab-mwge) - Roche
Soliris (eculizumab) - AstraZeneca
Ultomiris (ravulizumab-cwvz) - AstraZeneca
Truxima (rituximab-abbs) - Indukern, Teva, Mundipharma, Celltrion, Nippon Kayaku
Uplizna (inebilizumab-cdon) - Tanabe Pharma, Amgen
http://clinicaltrials.gov/ct2/show/NCT07010302
 
Feb 13, 2026
 
Next